Angiogenesis;
Non small cell lung cancer (NSCLC);
Vascular endothelial growth factor (VEGF);
Antiangiogenic agents;
D O I:
10.2478/v10034-008-0011-3
中图分类号:
Q3 [遗传学];
学科分类号:
071007 ;
090102 ;
摘要:
Non small cell lung cancer (NSCLC) accounts for approximately 80% of all lung cancers. Despite improvements in treatment protocols the survival rate in NSCLC remains poor. An improved understanding of cancer biology has led to the investigation of angiogenesis in NSCLC development and progression by intratumoral microvessel count or expression of angiogenic markers. The prognostic significance of several frequently assessed angiogenic factors and current antiangiogenic strategies which proved to be particularly promising in combination with chemo therapeutic agents for clinical management of NSCLC are here reviewed.
机构:
Univ Federico II Naples, Dept Publ Hlth, Naples, ItalyUniv Federico II Naples, Dept Publ Hlth, Naples, Italy
Malapelle, Umberto
Rossi, Antonio
论文数: 0引用数: 0
h-index: 0
机构:
Fdn IRCCS Casa Sollievo della Sofferenza, Div Med Oncol, Viale Padre Pio, I-71013 San Giovanni Rotondo, FG, ItalyUniv Federico II Naples, Dept Publ Hlth, Naples, Italy